{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-016077","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2021-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.887404+00:00","generated_at":"2026-06-30T07:25:42.063595+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Protagenic Therapeutics enters ATM equity offering agreement for up to $10M","bullets":["Entered into ATM Sales Agreement with B. Riley Securities and EF Hutton to sell up to $10M of common stock.","Commission of 3.0% of gross sales price; agents use commercially reasonable efforts to sell shares.","Offering made under S-3 shelf registration (No. 333-256790) effective June 23, 2021.","Company not obligated to sell shares; agreement can be terminated by either party upon notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-016077","json":"https://secwatch.observer/filing/0001493152-21-016077.json","markdown":"https://secwatch.observer/filing/0001493152-21-016077.md","text":"https://secwatch.observer/filing/0001493152-21-016077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221016077/0001493152-21-016077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315221016077/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T07:25:42.063595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}